Transcranial Magnetic Stimulation for Low Back Pain

Not Applicable

Withdrawn

• Conditions: Chronic Low Back Pain

• Registration Number: NCT02070016
• Lead Sponsor: Stanford University

Brief Summary

The purpose of this study is to test whether non-invasive brain stimulation, such as Transcranial Magnetic Stimulation (TMS) may alleviate pain associated with various chronic pain conditions. We will test various methods of TMS to identify a treatment approach that may reduce the symptoms of chronic pain for the patient.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-02-04
• Study First Submitted QC: 2014-02-20
• Study First Posted: 2014-02-24
• Primary Completion: 2014-10
• Study Completion: 2014-10
• Status Verified: 2015-08
• Last Update Submitted: 2015-08-05
• Last Update Posted: 2015-08-07

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Age 18 or older
• Patient with Chronic Low Back Pain
• Meets minimum pain level criteria
• Ability to perform the experimental Task and Procedures

Exclusion Criteria

• MRI contraindication if an MRI exam is required per protocol
• TMS Contraindication
• History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
• Neurologic illness that would interfere with brain integrity
• Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
• Currently pregnant or planning to become pregnant.
• On going legal action or disability claim.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Change in Average Daily Pain	Baseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks)	Compared to baseline pain report as provided by Visual Analogue Scale (VAS)
Change in Worst Daily Pain	Baseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks)	As compared to baseline worst daily pain report provided on visual analogue scale (VAS)

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Palo Alto, California, United States